David Schaefer
Chief Executive Officer
David has over 30 years of experience in biotechnology and healthcare, spanning diagnostics, medical devices, and therapies in infectious diseases, cardiology, immunology, and more. He has held leadership roles at Abbott Laboratories, Murex, and Ocean Optics, alongside start-up ventures like Nexan and Syntro. David has driven corporate investments, private equity transactions, and the growth of disruptive healthcare technologies. He has also consulted with Booz Allen & Hamilton and sponsored groundbreaking clinical studies in HIV resistance, sleep medicine, heart failure, and neuromuscular disorders. David holds a BS in Chemical Engineering and Biotech from Johns Hopkins University and an MBA from Northwestern’s Kellogg School of Management.